Download

Download Full Text (1.5 MB)

Contents

  • Preventing and Treating Graft-Versus-Host Disease After Stem Cell Transplantation: Each year, thousands of patients with hematologic malignancies undergo allogeneic (donor) stem cell transplantation (SCT), which offers a chance at cure. Graft-versus-host disease (GHVD) is a potentially deadly complication of this therapy and occurs in 25%-60% of patients. However, clinicians and researchers are continually working to reduce the rate of GVHD occurrance and improve patient outcomes
  • Compass: Breast cancer Risk Reduction: Women at increased risk have multiple options
  • HOUSE CALL: Benefits of In-Person Support Groups- Face-to-face contact helps people cope with chronic illness

Publication Date

4-1-2013

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Open

OncoLog, Volume 58, Number 04, April 2013

Share

COinS